# An In-vitro Standardization of B Cell Elispot Assays

> **NCT01334281** · — · TERMINATED · sponsor: **Northwestern University** · enrollment: 19 (actual)

## Conditions studied

- Transplant Sensitization
- Panel Reactive Antibody
- Sensitization to HLA Antigens

## Interventions

- **PROCEDURE:** Blood Draw
- **PROCEDURE:** Blood Draw

## Key facts

- **NCT ID:** NCT01334281
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2011-04
- **Final completion:** 2012-10
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Technical difficulties perfecting laboratory test used on blood samples.
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01334281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01334281, "An In-vitro Standardization of B Cell Elispot Assays". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01334281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*